达沙替尼 - Suppr | 超能文献

Suppr

超能文献

Dasatinib.

作者信息

Kantarjian Hagop, Jabbour Elias, Grimley Joanne, Kirkpatrick Peter

出版信息

Nat Rev Drug Discov. 2006 Sep;5(9):717-8. doi: 10.1038/nrd2135.

DOI:10.1038/nrd2135

PMID:17001803

Abstract

摘要

相似文献

Dasatinib.

Nat Rev Drug Discov. 2006 Sep;5(9):717-8. doi: 10.1038/nrd2135.

Dasatinib: for some difficult cases of adult leukaemia.

Prescrire Int. 2008 Aug;17(96):149-50.

Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.

Clin Ther. 2007 Nov;29(11):2289-308. doi: 10.1016/j.clinthera.2007.11.005.

Dasatinib (Sprycel) for CML and Ph + ALL.

Med Lett Drugs Ther. 2007 Jan 15;49(1252):6-7.

Dasatinib in chronic myelogenous leukemia.

N Engl J Med. 2006 Sep 7;355(10):1062-3; author reply 1063-4.

Presence or the emergence of a F317L BCR-ABL mutation may be associated with resistance to dasatinib in Philadelphia chromosome-positive leukemia.

J Clin Oncol. 2006 Nov 20;24(33):e51-2. doi: 10.1200/JCO.2006.08.9128.

New approved dasatinib regimen available for clinical use.

Expert Rev Anticancer Ther. 2009 Mar;9(3):285-92. doi: 10.1586/14737140.9.3.285.

[Pharmacological properties and clinical efficacy of dasatinib hydrate (Sprycel), an anticancer drug for chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia].

Nihon Yakurigaku Zasshi. 2009 Sep;134(3):159-67. doi: 10.1254/fpj.134.159.

Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias.

N Engl J Med. 2006 Jun 15;354(24):2531-41. doi: 10.1056/NEJMoa055229.

[Dasatinib. A novel tyrosine kinase inhibitor for the treatment of chronic myeloid leukaemia].

Ugeskr Laeger. 2008 Jan 28;170(5):331-3.

引用本文的文献

Hybrid thiazolyl-benzylidene-phenol metal complexes as novel chemotherapeutic agents with anti-topoisomerase I activity in human breast carcinoma: synthesis, and studies.

RSC Adv. 2025 Jun 17;15(26):20552-20569. doi: 10.1039/d5ra00889a. eCollection 2025 Jun 16.

Oxygen-carrying nanoemulsions and respiratory hyperoxia eliminate tumor hypoxia-induced immunosuppression.

JCI Insight. 2025 Mar 24;10(6):e174675. doi: 10.1172/jci.insight.174675.

Mechanistic insights into novel cyano-pyrimidine pendant chalcone derivatives as LSD1 inhibitors by docking, ADMET, MM/GBSA, and molecular dynamics simulation.

Biochem Biophys Rep. 2025 Feb 12;41:101937. doi: 10.1016/j.bbrep.2025.101937. eCollection 2025 Mar.

A generative deep neural network for pan-digestive tract cancer survival analysis.

BioData Min. 2025 Jan 27;18(1):9. doi: 10.1186/s13040-025-00426-z.

Multi-bioinformatics revealed potential biomarkers and repurposed drugs for gastric adenocarcinoma-related gastric intestinal metaplasia.

NPJ Syst Biol Appl. 2024 Nov 4;10(1):127. doi: 10.1038/s41540-024-00455-0.

A SRC-slug-TGFβ2 signaling axis drives poor outcomes in triple-negative breast cancers.

Cell Commun Signal. 2024 Sep 26;22(1):454. doi: 10.1186/s12964-024-01793-6.

Artificial intelligence in fusion protein three-dimensional structure prediction: Review and perspective.

Clin Transl Med. 2024 Aug;14(8):e1789. doi: 10.1002/ctm2.1789.

The Clinical Relevance of the EPH/Ephrin Signaling Pathway in Pediatric Solid and Hematologic Malignancies.

Int J Mol Sci. 2024 Mar 29;25(7):3834. doi: 10.3390/ijms25073834.

Glycaemic abnormalities induced by small molecule tryosine kinase inhibitors: a review.

Front Pharmacol. 2024 Feb 1;15:1355171. doi: 10.3389/fphar.2024.1355171. eCollection 2024.

SynergyX: a multi-modality mutual attention network for interpretable drug synergy prediction.

Brief Bioinform. 2024 Jan 22;25(2). doi: 10.1093/bib/bbae015.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验